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Abstract 
Referral management after biometric health screening is an integral component in the employee 
health model of care. Early detection and identification of health problems, counseling, follow-
up, and referral to a health care provider can improve patient outcomes. PURPOSE: The purpose 
of this project was to improve the referral management process after biometric screening at a 
central North Carolina employee health center. Biometric screening referrals for 2015 were 
reviewed. A sample of 420 screens revealed 84% of patients with abnormal biometric screens 
did not follow-up with the health center, therefore no further referral was completed. Using an 
updated biometric screening process and intervention tool, 2015 and 2016 data were then 
compared to assess for an improvement between the two years. METHODS: Random 
retrospective chart review and comparison was limited to selected months between January 
through June 2015 and 2016. Evaluation measures included the following: initial patient referral 
using intervention tool after biometric screening, contact with the employee after completion of 
the screening, documentation of the referral completion, and employee’s return to the health 
center. RESULTS: 2016 abnormal biometric screens were consistently referred for follow-up 
counseling using intervention tool. Evaluation of the data revealed process improvement 
in screening and referral consistency and documentation. Health center utilization improved 
between 2015 and 2016. A revised policy on referral management at the health center improved 
consistency between screeners, tracking of referrals, patient follow-up, and patient volume at the 
health center. CONCLUSIONS: Using a standardized referral process and intervention tool 
improved the biometric screening program in this central NC employee health center. 
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Chapter I: Introduction 
Biometric health screening in an employee health center is an essential component in 
promoting health and wellness in an employee heath population. The purpose of this quality 
improvement project (QIP) was to further develop the referral management process after 
biometric screening at an employee health center in North Carolina. Several studies have cited 
using biometric screening in employee-based health and wellness programs (Henke, Goetzel, 
McHugh, & Isaac, 2011; Goetzel and Ozminkowski, 2008, Goetzel et al., 2002). These studies 
have shown significant promise in improving employee health and reducing health expenditures 
for their companies. The process of biometric screening, counseling on results, and referral 
management after biometric screening is a topic of tremendous value to both employees and 
employers that has not been extensively studied in the literature. 
This project reviewed data from a large employee health center in North Carolina. Over 
5,000 employees were eligible to participate in biometric screening. Initial sample data was 
collected as part of the quality assurance process in 2015. This process (Table 1) revealed 84% 
of patients with abnormal screening results (elevated BMI, cholesterol, blood pressure, or 
glucose) did not follow-up with the health center, therefore no further health referral was 
completed for the employee with the abnormal screen. The intention of the biometric screening 
process for the company and its employees was to assist employees improve their health, and the 
overall health of the company. This project reviewed the biometric screening process including: 
screening documentation, following up on abnormal screens, and making appropriate referrals 
after their abnormal screens. 
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Table 1 
Sample of follow-up data of NC health center patients after biometric screening 2015 
  
  
 
N 
 
 BMI 
 
Glucose 
 
Lipids 
 
 BP 
 
Tobacco 
Total number of patients  437  309 114 175  78 15 
Total follow-up  420      
Total contacted & follow-up  59      
Total contacted & no follow-up   361    
  
Total reported PCP follow-up   9      
Total not eligible   17      
Total contacted  382      
Total not contacted  55      
 
Note. Total number of patients = total number of patients counseled in sample. Total follow-
up = total number of patients who were counseled and needed follow-up in health center. Total 
contacted & follow-up = total number who were counseled and did follow-up in health center. 
Contacted & no follow-up = total number who were counseled and who did not follow-up in 
health center. Total reported primary care provider (PCP) follow-up = total who reported follow-
up with primary care provider. Total not eligible = total not eligible for follow-up by health 
center. Total contacted = total contacted by health center. Total no contacted = total not 
contacted by health center. Lab values = 1 or more elevated values. BMI = BMI over 28. 
Glucose = >100. Fasting Lipids = at least 1 value elevated in lipid panel. BP = Blood pressure >. 
Tobacco = Tobacco user. 
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Problem Statement 
The United States and state of North Carolina spends billions of dollars on clinical 
testing, documentation, and health related complications related to obesity, diabetes, and 
hypertension (CDC, 2015f). The North Carolina employee health center being studied serves 
patients in multiple states and spends a significant percentage of its employee health care dollars 
on heart disease, diabetes, and obesity related health problems (BCBS NC, 2015; Stroke, 2012). 
Furthermore, the cost to this company and the company’s employees appears to be rising yearly 
(Alexander, Garloch, & Neff, 2012; BCBS NC, 2015; Stroke 2012). 
Accordingly, programs focusing on improving employee health screening and managing 
abnormal values through appropriate follow-up and referral are beneficial to both employees and 
corporations (Goetzel et al., 2014; Volpp, Asch, Galvin, & Loewenstein, 2012). Employer-based 
biometric screening and wellness programs have the potential to improve patient health 
outcomes and decrease health care spending. The average American spends a third of their day at 
work, thus incorporating screening, tracking, and managing referrals on these health issues can 
serve the multiple roles of increased employee health, wellness, and lower health care costs 
(CDC, 2014b).  
Purpose 
The purpose of this project is to improve the documentation, follow-up, and referral 
management process at an employee health center. The change in practice occurred between 
2015 and 2016. A retrospective chart review was completed between June 2016 and August 
2016. This data was collected to measure the improvement of this QIP. The health center 
evaluated our current referral policy/practice which varied between screener (Table 5) and 
13 
 
standardize it between screeners (Table 6). This included evaluation, education, documentation, 
and patient follow-up.  
Background 
The initial biometric screening occurred at the health center between January and June of 
2015. Prior to this time, biometric screening was performed outside of the health center by a 
corporate partner. The health center proposed completing the biometric screening process using 
available clinical staff in the employee health center and provide point of care testing. This 
proposal included potential cost savings (reduced labor cost) and potential improvement in 
quality of care (e.g. same day results). The plan for transition started in 2014 and was completed 
in 2015. The biometric screening process was repeated in 2016 and scheduled again for 2017. 
As part of our organization’s quality assurance and improvement process for screening at 
the health center, a sample of referral management and biometric data (Table 1) was collected on 
employees whose 2015 screenings showed abnormal results. The aforementioned 2015 screening 
included body mass index, lipids, fasting glucose, blood pressure, and nicotine/cotinine levels. 
Cotinine levels were not checked in 2016. The sample of 420 screens revealed that 84% of 
patients with abnormal biometric screens did not follow-up with the health center, therefore no 
further referral was completed. This projects goal was to improve the biometric screening and 
referral process for employees in the NC employee health in 2016, and improve the process for 
future screening years. 
After review of the screening process in 2015 (Table 5), several health management team 
issues were identified. First, a lack of clear referral guidelines between screeners was identified 
and a new referral tool was created and agreed upon (Table 6). Second, clinical roles in the 
health center were not clearly defined, resistance to the work flow was encountered, and 
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skepticism of the results was reported. For example, medical assistants questioned roles, and 
2014 data was not available to benchmark our 2015 results. Bi-monthly meetings were held with 
providers (nurse practitioners), registered dietitian, health center manager, nurses, and medical 
assistants. Quarterly meetings were held with aforementioned clinical personnel, medical 
director (physician) and employer representative. The new tool was implemented (Table 6), 
clinical roles were reviewed, and employee work flow was discussed (Appendix B). The primary 
investigator applied Rogers’ work on the diffusion of innovation to the process (Rogers, 2010). 
This provided greater understanding of the relationship between the employer, screener, and 
employee participant during a biometric screening process. Furthermore, it supported tolerance 
of a wide range of behavior experienced by the primary investigator, clinical staff, and company 
leadership during the project (Figure 2). 
Clearly record redundancy created confusion; this was an ongoing issue and was greatly 
improved by scanning paper records into the electronic medical record. For example, data was 
stored in multiple computer programs which did not communicate with each other and a paper 
copy was filed. This redundancy in clinical records led to duplicate tests, misfiling, lack of 
referral, and inconsistent follow-up procedures between screeners. Inefficient documentation 
(e.g. documenting the same information 3 or 4 times) was noted by all screeners. Additionally, 
clinical roles related to biometric screening and referral needed reiteration and workflow 
concerns discussed and adjusted. The 2016 project improved clinical documentation and the 
referral management process, and will be continued in 2017. The creation and implementation of 
a referral management intervention tool (Table 6) made a difference in clinical documentation 
and participant follow-up, the results were reviewed and evaluated for quality assurance. The 
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quality assurance component of this project was completed in summer 2016 and included a chart 
review. 
Quality Improvement Questions: 
 To date, research has explored the importance of biometric screening yet there is a 
limited amount of QIPs reviewing the importance of referral management after biometric screen 
at an employee health center. Based on the literature discussed in the evidence-based practices 
section, the principal investigator developed four quality improvement questions: 
1. Does a consistent referral management process, using intervention tool, including participant 
tracking, and participant follow-up, make a difference in clinical documentation of the 
participant screen? Does the EHR have a biometric screen in 2015? In 2016? 
2. Is there is a difference in clinical documentation with a consistent referral management 
process, including tacking and participant follow-up, in clinical documentation at the health 
center. Does the EHR have a referral? Did the health center contact the participant? Did the 
participant return to the health center? 
3. Does a consistent referral management process, including tracking, and participant follow-up 
make a difference in observed patient volume at the health center? 
4. What is the frequency of referrals for elevated body mass index, elevated glucose, elevated 
cholesterol, elevated lipids, and elevated blood pressure? 
Definition of Terms 
The following terms are operationalized as follows in the project: 
Attended visit: Employee participant has a visit to the health center. 
Biometric Screening: the measurement of objective physical features such as height, weight, 
body mass index, blood pressure, blood cholesterol, blood glucose, and physical fitness tests that 
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can be measured at a employee health center and used as part of a health screening to assess and 
evaluate changes in employee participant health status over time (CDC, 2015c). 
Blood Pressure (BP): is the measure is the force of blood pushing against the walls of the 
arteries that carry blood from your heart to other parts of your body. Blood pressure normally 
rises and falls throughout the day, but it can damage your heart and cause health problems if it 
stays high for a long time. High blood pressure is also called hypertension. This is consistent 
with the CDC (2015a) guidelines for screening asymptomatic adults. 
Body Mass Index-BMI: is used as a screening tool for overweight or obesity. BMI is a person’s 
weight in kilograms divided by the square of height in meters. The formula for BMI is weight in 
pounds (lbs) divided by height in inches (in) squared and multiplied by a conversion factor of 
703. A BMI range of >17 and < 28 has been set as an individual goal body mass for the 
employee population. This is consistent with the CDC (2015d), and NIH guidelines for screening 
asymptomatic adults. 
Cholesterol and Lipid Testing: is the measure of cholesterol and lipids, waxy fat-like 
substances that travel through the blood. Cholesterol and Lipid testing defined in this project is 
consistent with the CDC (2015b) guidelines for screening asymptomatic adults. 
Diffusion of Innovation with Biometric Screening in Employee Health: process which 
employees experience when receiving personal health information from employer sponsored 
program. This process is also experienced by employees facilitating program (Rogers, 2010). 
Electronic Health Record/EHR: electronic database at employee health center utilized for chart 
review. 
Follow-Up Visit: a visit documented in the EHR for counseling on abnormal biometric 
screening results. 
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Glucose Testing: is the measure of blood sugar in the human body. Normal Glucose is 60–100 
mg/dl. Glucose testing defined in this project is consistent with the American Diabetes 
Association (ADA, 2015) guidelines for screening asymptomatic adults. 
Hemoglobin A1c testing: the measure of blood sugar in the human body over 3 months. A 
normal hemoglobin A1c is < 5.7, this correlates to an average blood sugar of 117. This is 
consistent with ADA guidelines for screening asymptomatic adults (ADA 2015). 
Nonclinical Disease in Employees with Abnormal Biometric Screens: biometric 
measurements indicate an increased risk of the employee developing a disease, e.g. elevated 
fasting blood sugar in non-diabetic employee. Clinical symptoms of the disease have not been 
observed or experienced by the employee. 
Office Visit: a regular office visit documented in the EMR after biometric screening. 
Patient Deferral: Employee with abnormal screen who deferred further counseling with health 
provider. 
Point of Care Testing: objective health screening/testing employees and counseling on results at 
the same visit. 
Population Health Team: Team responsible for the larger health promotion project. This 
project group was separate from this team and did collect data and coordinate with this team. 
Post-Screening Follow-up message: Additional follow-up message sent to employee with 
abnormal biometric screen. 
Referral: employee directed to additional health resources after biometric screen. 
Referral Management: is a process whereby an employee is introduced and directed to 
additional health resources within the health center or the community. This process should 
include documentation in the EHR, documented follow-up, and documented patient response. 
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Return on Investment in employee health (ROI): Cost of the program subtracted from the 
benefits the program. Employers want to see their investment pay dividends for the company. 
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 Biometric screen at employer health center. 
 
 
 
 
 
 
 
 
 
Follow-up by health center   Review or Counseling 
 as needed 
 
 
 
 
 
 
 
 
Referral +/- 
 
 
Figure 1. The biometric screening and referral management loop. 
Note. Theoretical design of biometric screening program. Arrows imply directionality of 
employee in biometric screening program. Employee elects to take part in screening. 
Confidential measurements are taken and coded. Counseling is completed after screen. If the 
employee receives a referral, the health center manages the referral, and follows-up on the 
referral. Repeat screen per clinical guidelines. Negative referrals flow back to screening agent, 
counseling and information on health center provided. The program is then repeated or 
completed (see Figure 1). As this was a new process for the employee health center, Rogers’ 
work on the diffusion of innovation provided a theoretical framework for understanding 
resistance to the biometric screening program (Rogers, 2010). 
 
 
Biometric screening 
program.  
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Chapter II: Research-Based Evidence 
Reviewing the literature on biometric screening, referral patterns, and employee follow-
up over the last five to ten years using multiple terms (screening, employees, referral, referral 
management, biometric screening, employee health, occupational health, health promotion, and 
health care economics) reveals how little is known about referral management after biometric 
screening in employee health (Table 4). This study used meta-analysis, systematic reviews, 
original research, policy statements by private and governmental organizations, and expert 
opinions expressed in printed literature to review existing evidence on improving referral 
management after biometric screening. For example, Baxter, Sanderson, Venn, Blizzard, & 
Palmer (2014) completed a meta-analysis on the return on investment in employee health 
programs using biometric screening and found that the data supported a favorable return for 
employers. Although they noted that the amount of return depended on the quality of the study; 
interestingly, the higher the quality of the study, the lower return on investment. Referral for 
disease management has a favorable return on investment, and controlling costs related to 
disease management is key for positive investment return. There does not seem to be a consensus 
in the literature about the best way to manage referrals after a positive biometric screen in 
employee health centers. 
The US Centers for Disease Control and Prevention (CDC, 2015c) defines biometric 
screening as the measurement of physical characteristics such as BMI, lipids, fasting glucose, 
blood pressure and aerobic fitness at a worksite. The CDC (2015f) states that elevated BMI, 
glucose, lipids, and blood pressure have been associated with increased risk for developing heart 
disease, stroke, diabetes, vascular disease, mobility issues, and reduced longevity. However, the 
reviewed literature does not specifically define a referral and follow-up procedure after biometric 
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screening in employee health. The CDC (2015f) loosely defines a referral as a provider, nurse, or 
other clinical agent advising a patient of their need for further consultation with a provider. 
Further research is needed into patient noncompliance issues and referral back to an employee 
health center (Arena et al., 2014). 
Calls for further research on clinical coordination between screening, disease 
management, and wellness programming exist (Goetzel et al. 2014.; Henke, Goetzel, Mchugh, & 
Issac, 2011; Goetzel and Ozminkowski, 2008; Goetzel et al., 2002). Multiple studies by Goetzel, 
dating back to 2002, all clearly discuss the importance of screening, disease management, and 
wellness programming in employee health. Dement, Epling, Joyner, and Cavanaugh (2015). 
continue reporting literature dating back to the 1980’s discussing the benefits of biometric 
screening and employee health. A systematic review by Soler et al. (2010) reviewed studies from 
1980-2005 provides evidence of the value of employee health screening and the need for 
coordinated interventions after screening over the last 25 years. For example, Soler et al. (2010) 
note that cholesterol reduction was considered significant while mean blood pressure was not; 
screening was found to be beneficial, and the authors note that further research on screening and 
management using more objective measurements (most of the studies relied on self-report) was 
needed. Bellew, St George, and King, (2012), who report that ample evidence for the value of 
biometric screening exists, also discuss the importance of linking biometric screenings with 
wellness programming. Johnson & Johnson, a company that is considered a corporate leader in 
employee health, reports a significant savings when biometric screening is linked with wellness 
interventions (Henke et al., 2011). Blue Cross and Blue Shield of Kansas City had success with 
an online health assessment (Colkesen et al., 2011). Baicker, Cutler, & Song (2010) report 
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wellness programs can generate savings for employers. Further research is needed to clarify the 
role of referral management after biometric screening in employee health 
The American College of Occupational and Environmental Medicine (Behling et al., 
2013) has a consensus statement on employer biometric health screening. It clearly outlines the 
important role biometric screening can play in a well-coordinated employee health and wellness 
program. Yet their recommendations on referral management to health providers and follow-up 
by the health and wellness agency are not clearly defined. They emphasize that screenings are 
not a replacement for medical examinations or wellness visits with a provider, but they do not 
specify whether referral and follow-up make any difference. The American Heart Association 
(Arena et al., 2014) has an excellent policy statement and suggests further research on the 
predictors of noncompliance in adopting healthier lifestyles after employee screening. Curry, 
Grossman, Whitlock, and Cantu (2014) discuss the importance of evidence-based behavioral 
counseling after health screening. 
Referral Management 
A consistent referral and management process after biometric screening in an employee 
health setting can assist patients in receiving the highest quality care (Arena et al., 2014). 
Improving the management of biometric referrals and consistent biometric follow-up can assist 
in employee health center predictions of patient volume, clinical utilization, and projected costs 
(Arena et al., 2014; Goetzel et al, 2002). This process reflects a fundamental paradigm shift 
occurring over the last decade, accelerated by the Affordable Care Act (Blumenthal, Abrams, & 
Nuzum, 2015). The Affordable Care Act (ACA) has refocused the healthcare industry on early 
identification and management of risk factors contributing to a higher risk for nonclinical 
disease: particularly obesity, cardiovascular dx, diabetes, and hypertension (Arena et al, 2014). 
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Providers hoping to have clinical success with biometric screening and patient follow-up in 
employee health should consistently review screening methods, results, patient counseling, and 
reported care for all employees being screened (Arena et al., 2014). For example, many 
biometric programs claim to provide quality care, yet never define how they track and follow up 
with employees in their model or program. Bridging the screening, follow-up, and referral gap in 
an employee health setting is essential. 
Elevated BMI/Obesity 
Elevated body mass and obesity is a growing epidemic in American companies. 
According to the CDC (2014a), approximately, one-third, or 34.9%, of American workers can be 
classified as obese (BMI >30), and another 40% can be classified as overweight or having an 
elevated BMI (BMI > 25). The cost of treating obesity within the US healthcare system is 
estimated at $147 billion per year and rising yearly (CDC, 2014d). 
Referral management for elevated BMI and obese patients is challenging in any clinical 
environment. For example, addressing patient and provider BMI, bias, and clinical expectations 
in an employee health center is difficult. The nature of sedentary work expectations, increased 
stress, and availability of high calorie food contribute to excess weight (CDC, 2014d). 
Evaluating employer and employee motives and incentives are crucial for program success 
(Wing et al., 2006). Employee health centers should develop standard screening and referral 
programs to address this unhealthy trend in the data (CDC, 2015f). 
Furthermore, human behavior regarding eating patterns and weight gain, weight loss, and 
weight maintenance are complex (CDC, 2014d). The importance of relationships between 
screeners, providers, and their obese patients in initiating and maintaining biometric screening 
and referral management is central for program success (Wing et al., 2006). For example, 
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Watson’s (2008) theory of human caring can explain and guide the process (McEwen & Willis, 
2011). It can provide a foundational aspect of a caring relationship between screeners, providers, 
and their biometric/bariatric patient (Butts & Rich, 2015). Caring for a patient is the starting 
point and basis for initiating and maintaining a therapeutic relationship with an employee in an 
employee health setting (Table 6). Addressing the intricacies of increasing BMI in an employee 
health setting is important for referral management. 
Cholesterol 
The Expert Adult Treatment Panel (ATP III) of the National Cholesterol Education 
Program (NCEP) has recommended cholesterol testing (2001) for patients requesting 
cardiovascular risk assessment or a family history of cardiovascular disease. Sample data from 
the central NC project site (Table 1) revealed that 40% of employees had abnormal cholesterol 
values (total cholesterol >200 mg/dl, low-density lipoprotein >150 mg/dl, triglycerides >150 
mg/dl; see Table 2). Additionally, claims data from a 2015 report cited cardiovascular disease as 
the third most common diagnostic set of codes for employees (BCBS NC, 2015). The 
aforementioned ATP III guidelines describe how elevated cholesterol levels can result in 
increased fatty deposits in human arteries, including those around the heart, which can lead to 
narrowing of the arteries and to heart disease (Grundy et al., 2004). 
In 2010, the economic costs of cardiovascular disease and stroke in the United States 
were estimated at $444.2 billion, including $272.5 billion in direct medical expenses and $171.7 
billion in indirect costs (CDC, 2015f). Elevated cholesterol is one of the major risk factors for 
heart disease and contributes to health care expenditures in the US and NC. It has been 
established that the central NC employer has an interest in improving employee health and 
reducing the impact of elevated cholesterol on cardiovascular disease. 
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The following guidelines, synthesized from the guidelines produced by ATP III (2004) 
and Gillespie, Keenan, Miner, Hong, and CDC (2012), outline best practices for cholesterol 
screening. 
According to ATP III and the CDC (2015b): 
 Screening should include total cholesterol/lipoprotein, low-density lipoprotein (i.e., LDL 
cholesterol), high-density lipoprotein (i.e., HDL cholesterol) and triglyceride levels. 
Screening tests should use blood from a person who has fasted for at least 12 hours. 
Table (2) outlines the lipoprotein parameters. 
 Screeners should note employees with elevated BMI, cholesterol, type 1 or type 2 
diabetes, and high blood pressure, as they have an even greater risk of heart attack; these 
patients should be encouraged to receive further risk evaluation and counseling. 
Elevated Glucose and Type 2 Diabetes. 
The American Diabetes Association (2015) has recommended glucose screening for 
groups who have a BMI over 25; are not physically active; have positive family history, 
hypertension, lipid problems; and are over 45. The data (Table 1) collected for employees 
suggests (26% had elevated blood glucose, serum glucose >100 mg/dl) that screening for 
elevated blood sugar and for type 2 diabetes is indicated. Employees with elevated fasting blood 
sugar or prediabetes have an abnormally high blood glucose level that is not elevated enough to 
be classified as diabetes. Employees with prediabetes are at high risk for developing type 2 
diabetes (CDC, 2015d). 
 Type 2 diabetes accounts for about 90% to 95% of all diagnosed cases of diabetes 
(ADA, 2015). Uncontrolled blood sugar and type 2 diabetes affects productivity at work (CDC, 
2015f). Screening and management for type 2 diabetes and elevated blood sugars (prediabetes) in 
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an employee health population can help prevent complications that can affect the eyes, kidneys, 
and nervous system (CDC, 2015f). Learning to control blood sugar is essential for management 
of diabetes. Screening for and management of prediabetes and type 2 diabetes can greatly reduce 
the risk of developing diabetes complications (CDC, 2015e). 
BMI/obesity is a major risk factor for type 2 diabetes. A greater workplace emphasis on 
glucose screening in overweight and obese employee populations is crucial for early 
identification of prediabetes and diabetes (CDC, 2015f). Employers can reduce the frequency 
and the effects of type 2 diabetes in their workforce through regular screening and management. 
Furthermore, diabetes in all its forms is costly in the working population (CDC, 2015b). The 
total estimated costs of diabetes were $174 billion, including $116 billion in medical 
expenditures and $58 billion in lost productivity. Indirect costs include absenteeism ($2.6 
billion), reduced productivity ($20 billion) for the employed population, reduced productivity 
($0.8 billion) for those not in the labor force, unemployment for disease-related disability ($7.9 
billion), and lost productive capacity due to early mortality ($26.9 billion) 
High Blood Pressure/Hypertension 
The US preventive task force (Siu, 2015) recommends screening for high blood pressure 
(>120/80 mm Hg) in adults 18 years or older. Sample data (Table 1) revealed that 18% of 
employees had elevated blood pressure. According to the CDC (2015a), chronically elevated 
blood pressure or hypertension is consistently one of the top ten most expensive health problems 
for American employers. The cost of hypertension in the United States has been estimated at 
$76.6 billion (CDC). Moreover, high blood pressure over time can cause heart disease, stroke, 
kidney disease, and blindness (James et al., 2014). The purpose of blood pressure screening is to 
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identify people with high blood pressure levels and refer them for clinical evaluation and 
treatment. 
Relevance to Intended Population 
The NC health center identified 5,000 employees eligible for participation in the Premise 
biometric screening program for 2015. The health center screened 4,157, or 83% of, the eligible 
employees (Premise Health, 2015). Early identification of preventable disease of employees 
through screening, counseling, referral, and follow-up (Figure 1) mirrors the changing standards 
in the healthcare system in the United States (Arena et al., 2014). Increased emphasis on early 
identification and management of risk factors associated chronic diseases (e.g. heart disease, and 
diabetes) is relevant for the employees utilizing the health center (Arena et al., 2014). Risk 
factors associated with preventing heart disease and diabetes have been identified as areas that 
impact employee health and decrease employer costs (Goetzel & Ozminkowski, 2008). The NC 
employer has requested additional programming on reducing obesity, heart disease, and diabetes 
in their employee population. 
Theoretical Framework 
The diffusion of innovation theory (Rogers, 2010) is the theoretical foundation for this 
project (Figure 2). Biometric screening and counseling in employee health is an innovative idea 
being encouraged by companies seeking to decrease the cost of their insurance premiums and 
improve employee health. Managing the follow-up and referral process at a central NC employee 
health center will potentially increase the utilization of the employee health centers and identify 
health concerns before they become problems. Traditionalists often criticize the role of 
employer-based programs and are slow to adopt new ways of receiving health services. 
Innovators argue that the ACA (Blumenthal, Abrams, & Nuzum, 2015) has legislated the 
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importance of healthy behavior, including individuals carrying health insurance. This law has an 
individual mandate and guidelines for both health providers and health insurance companies. 
Therefore, this theoretical model, which explains the diffusion of innovation of biometric 
screening in an employee health center and closes the loop on the clinical referral and follow-up 
process (Figure 2), fits perfectly as a theoretical framework. 
Rogers (2010) classifies five groups of people who will adopt the change in process. The 
types explained in the model correspond to individuals represent employees in this model: 
1. Innovators—The employees who want to be the first to schedule at the health center and 
try the innovation. These people are very willing to take risks, and are often the first to 
develop new ideas. Very little, if anything, needs to be done to appeal to this population. 
2. Early Adopters—These are opinion leaders in the company. They enjoy leadership roles, 
and embrace the health center. They are already aware of the need to change and so are 
very comfortable adopting new health center ideas.  
3. Early Majority—These employees are rarely leaders, but they do adopt new health center 
ideas before the average employee. That said, they typically need to see evidence that the 
innovation works before they are willing to adopt it.  
4. Late Majority—These employees are skeptical of change, and will only adopt an 
innovation after it has been tried by the majority. Strategies to appeal to this population 
include information on how many other employees have tried the innovation and have 
adopted it successfully. 
5. Laggards—These employees are bound by tradition and very conservative. They are very 
skeptical of change and are the hardest group to bring on board. Strategies to appeal to 
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this population include statistics, fear appeals, and pressure from employees in the other 
adopter groups.  
(Boston University of Public Health, 2013) 
Furthermore, Sare and Ogilve (2010) assisted in the conceptualization of the nursing 
problem (Table 2) assisted in the design of this QIP. This QIP identified a lack of a standardized 
referral tool, a lack of consistent clinical follow-up, and a lack of data on referrals after abnormal 
test results. The health center reviewed patient charts and screening tests and determined that 
providers and clinical staff were consistent with follow-up and referral after biometric screening. 
Improving referral and follow-up has been theorized to improve the biometric screening process. 
 
 
 
Figure 2. Rogers’ diffusion of Innovation theory 
Note. “The stages by which a person adopts an innovation, and whereby diffusion is 
accomplished, include awareness of the need for an innovation, decision to adopt (or reject) the 
innovation, initial use of the innovation to test it, and continued use of the innovation. There are 
five main factors that influence adoption of an innovation, and each of these factors is at play to 
a different extent in the five adopter categories.” (Boston University of Public Health, 2013) 
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Table 2  
The components of biometric project theory 
  
1. Observation. lack of consistent clinical referral and F/U 
2. Observational experience-Chart review 
3. Assumption-consistent referral and F/U affects utilization.  
4. Supporting concepts-lack of evidence on referral and F/U. 
5 Hypothesis is formed 
HO- Referral management makes no difference on pt visits 
HA-Referral management shows a difference 
6. 
7. 
Theoretical models reviewed and created 
Further data collection, literature review, and training 
planned 
 
Notes. The seven components of theory, Adapted from Sare & Ogilvie (2010). F/U = Follow-up. 
pt = patient. HO = null hypothesis. HA = alternative hypothesis 
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Chapter III: Methods  
The purpose of this quality improvement (QI) project was to improve the documentation, 
follow-up, and referral management process at an employee health center in central North 
Carolina (NC). The employee health center evaluated in this project serves 5000 employees of a 
central NC company. The health center team was composed of a physician medical director 
(MD), full time nurse practitioner (NP), multiple part time nurse practitioners, a health center 
manager who was a registered nurse (RN), a registered dietician (RD), a part time physician, and 
two medical assistants (MAs). Team members received no additional compensation (beyond 
their regular wages) for their participation in this project. This QI project occurred between 2015 
and 2016 and was part of a larger health promotion project, which is not evaluated here. Data 
was shared between programs; pertinent population health data was included in this QI project as 
a reference (Table 3). Employee demographic variables were not analyzed in the QI project. The 
basis of the QI project was the evaluation of the health center’s referral policies and practices 
after biometric screenings, which varied by screener (Table 5). The project team then 
standardized the referral process with the creation of an updated referral tool, making it 
consistent across all screeners (Table 6), and measured the impact of this standardization on 
participants’ post-screening health behavior. The project included evaluation, education, 
documentation, and patient follow-up. 
Sample 
In 2015 and 2016, 5,000 employees were eligible to participate in the biometric screening 
program. Of these 5,000 eligible employees, the health center screened 4,157 employees (83% of 
eligible employees) in 2015 and 4200 employees (84% of eligible employees) in 2016. To track 
the effects of the change in referral policies and procedures, a random sample of 420 employees 
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with abnormal screens (hereafter referred to as “participants”) was collected in 2015 and tracked 
through 2016. In 2016, this same cohort of participants (with some attrition; only 406 of the 
original 420 participants were still eligible for employee health screenings in 2016) was screened 
again and again referred for follow-up; their behaviors after referral were reviewed to examine 
the effects of the new, standardized referral processes. 
The screening process was as follows. Eligible screening candidates made online or 
phone appointments with the health center according to their schedules. During the scheduled 
screening periods (January through June 2015 and January through July 2016), the health center 
had regular hours (7:30–4:30 Monday through Friday) and dedicated 3–4 hours of clinical time 
per day to screenings. Screens were completed based on appointment time and/or participant 
arrival time. Three screens could be completed per time slot, and screens were randomly 
assigned to screeners based on participant arrival time. A 10% sample of total population 
screened by heath center was established by primary investigator. This sample size was 
supported in the literature (Israel, 1992) 
Procedures, Data Collection, and Ethics 
Organizational approval was obtained (Appendix A) and internal review was completed 
by East Carolina University (Appendix A). All data was confidentially kept in a password 
encrypted computer in a locked office. Screeners recorded data on our approved paper screening 
tool (Appendix D): fasting cholesterol, lipids, glucose, height, weight, and blood pressure. Data 
was shared with the employee. In 2015, (pre-intervention), the screening data was not entered 
into the health center EHR database; instead, paper records were collected and alphabetically 
organized. During this period, there was no standardized referral and follow-up procedure, and 
screeners decided independently whether to tell participants to get further tests, to see their 
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primary care physician, or to simply recommend follow-up. In 2016, the post-intervention 
process included scanning a copy of the screening tool into the EHR and using a standard referral 
and follow-up tool; for abnormal results, follow-up appointments were encouraged, and when 
possible, were scheduled for the participant using the standard referral tool. Figure 3 is a process 
map that outlines the biometric screening and referral process for 2015; it also shows where 
issues were identified and changes that were made to the process in 2016. Using the updated 
referral process (Table 6), abnormal screens identified in 2016 were referred back to the health 
center or to an outside provider, and red-flag values were reviewed by a nurse practitioner. 
Figure 4 outlines the QI process which occurred after the referral. 
 
Figure 3. Process map: Proposed biometric flow of patients at BCBS NC-Durham. 
 
Health Center collects sample data on biometric program. 
Evaluation of sample data revealed referral process and 
managment issue. 
Health Center reviews and documents process and 
creates new referral guidelines and referral tool, reviews 
2016 clinical flow and expectations.
Health Center implements new referral and follow-up 
guidelines. 
Heath center continues 2015 data review of patients and 
starts comparison data review of 2016 Data.
Health Center completes and presents 2015 and 2016 
data comparison
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Figure 4. Process for retrospective chart review.  
Each box represents a step in the review process. First, chart is reviewed for referral. If referral was made, 
notation on type of referral and follow-up (F/U) was documented. The chart was then reviewed for a 
return visit to the health center or follow-up message for the patient. Randomized charts were reviewed to 
avoid duplication. A workbook was kept on reviewed charts; see Appendix B. 
 
Data Analysis 
After sampling was completed (n = 406), the primary investigator reviewed the data for 2015 and 
2016, reviewing, tracking, and comparing charts. Figure 4 gives an overview of the comparative 
and retrospective chart review. Descriptive statistics (Microsoft Excel) were utilized for analysis. 
Timeline 
 This project was carried out from September 2015 through September 2016. Appendix C 
outlines the timeline for the project. 
Referral after 
screen +/-
(+)
Internal
F/U message
+/-
+ 
Return message or 
F/U  visit
+/-
-
Return message or  
F/U  visit
+/-
External
F/U message
+/-
+
Return message or 
F/U visit
+/-
-
Return message or 
F/U visit
+/-
(-) Return message or F/U visit  +/-
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Evaluation Method 
Clinical questions were evaluated by chart review. The data was collected from the EHR 
and placed into a Microsoft Excel spreadsheet (Appendix B). First, the referral process was 
assessed. Was a referral given to the employee? Did the employee/patient accept or defer the 
referral? Did the employee/patient return to the health center? The new process and referral tool 
was implemented in 2016 and data was compared between 2015 and 2016. An Excel spreadsheet 
was kept and reviewed daily and updated. The data set is available on request. 
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Chapter IV: Results 
 The purpose of this QIP was to improve the referral process after biometric screening at a 
central North Carolina employee health center. Biometric screening referrals for 2015 and 2016 
were reviewed. 
Sample Descriptive Statistics 
5,000 employees were eligible for participation in the biometric screening program for 
2015 and 2016. In 2015, the central North Carolina health center screened 4,157 employees 
(83% of the eligible employees). In 2016, 3,442 employees (69% of the eligible employees) were 
screened by the health center, and 758 of the remaining eligible employees were screened by 
outside providers rather than at the research site; thus, a total of 4,200 employees (84% of 
eligible employees) were screened in 2016 (Premise Health, 2016). The primary investigator 
collected a random sample (see methods) of 420 participants with abnormal screens in 2015 and 
tracked these participants from 2015 to 2016. In 2016, this same cohort of participants was re-
screened and re-referred for follow-up. Only 406 of 2015’s original 420-participant cohort were 
available for comparison in 2016; after updating the sample by comparing against employee 
records and testing for eligibility, 336 of the original participants, or 83% of the sample, were 
available for comparison. (This participant attrition is in part due to changing participant 
eligibility for the health screenings.) 
Screens were reviewed in the EHR. 406 screens were evaluated for eligibility; 336 (83% 
of the sample) of these participants were eligible for comparison, meaning that in both 2015 and 
2016 they were eligible for the biometric program and participated in the screenings. In 2015, the 
total number of referrals was 522; in 2016, the total number of referrals was 449. This analysis 
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does not include the 758 screens completed by outside providers or the data set collected by the 
larger health promotion project. 
Table 3 
Comparison of biometric data 2015–2016 
 
 Sample population data 
 n % N % 
Total screens reviewed 2015 406 10%** 4157 10% reviewed 
Total screens reviewed 2016 406 12%** 3442** 10% reviewed 
Total referrals 2015  522 13%** *** *** 
Total referrals 2016 449 13%** 2415 70%* 
Total referrals attended 2015 36 11%* *** *** 
Total referrals attended (first 6 months 
of 2016) 58  
 
17%* 
 
237 
 
10%** 
Referral attendance projection for 2016 116 34%* 474 20%** 
Total deferrals by employees 2015 100 30%* *** *** 
Total deferrals by employees 2016 142 42%* 1252 52% 
Tracked provider visits 2015, Q2   453 *** 
Tracked provider visits 2016, Q2   656  
 
Note. * = Data was rounded, 2015, 2016 data based on completed and eligible screens n = 336. 
screens. ** = Data based on health center screening. *** Data not available. **** = Data was 
estimated. Emp = Employees. Comp = Completed. Q2 = Quarter 2: April, May, June. 
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Quality Improvement Question 1 
The first QI question was: “Does a consistent referral management process, using 
intervention tool, make a difference in clinical documentation of the participant screen? Does the 
EHR have a biometric screen in 2015? In 2016?” This question was intended to ensure that each 
participant whose records were compared were indeed eligible in both 2015 and 2016. 
Of the 406 screens from 2015 that were reviewed, 3 of these screens (0.8%, or < 1%) 
were documented in the EHR; the remaining screens were pulled from paper notes and placed 
into an Excel spreadsheet for comparison. The review of three screens in the EHR in 2015 
highlights a clinical documentation issue in 2015. Team members requested an improved 
documentation process, and scanned 2016 biometric results in the EHR. In 2016, 322 of these 
406 screens (79%), were fully documented in the EHR; 3 were usable and not documented in the 
EHR. In other words, 81 participants changed status between 2015 and 2016. Fifty of these 
participants (12%) were lost because they were no longer eligible for the biometric screening 
program in 2016. Twenty more (5%) completed the 2016 screen, but their records were either 
unusable or not fully documented. 14 (3%) of screens were usable and not fully documented. A 
clear difference in documentation was produced when screens were scanned into the EHR, 
preferably during the screening session; of screens that were entered into the EHR on the same 
day, 336 screens, or 83%, were found to be eligible for comparison, 3 were not documented in 
EHR, 11 were not fully documented. This simple process change created more initial work for 
the project team in 2016 and did save work after the screen were completed. Figure 5, clearly 
displays tangible results. Clinicians found that the EHR’s initial follow-up message and 
subsequent communication to the employee was well received, easy to find in the EHR, and 
usable during future patient encounters. 
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Figure Error! Unknown switch argument.. Biometric screens documented in EHR, 2015–2016.  
2015 records were primarily kept on paper and documented on a separate cloud-based computer server. 
2016 screens were scanned into the EHR and the cloud-based computer server. To be included in the 
analysis, screens needed to meet eligibility criteria and have screening data for both 2015 and 2016. 
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Quality Improvement Question 2 
The second QI question was: “Is there is a difference in clinical documentation at the 
health center with a consistent referral management process, including clinical tracking and 
participant follow-up? Does the EHR have a referral? Did the participant return to the health 
center?” 
Upon review, 406 sample screens, 336 of 406 (83%), were usable and documented in the 
EHR. The total number of documented referrals for 2015 was 522. Total number of referrals for 
2016 was 449, for a total number of referrals (2015–2016) of 971. However, screeners did not 
always clearly document every referral; this issue was addressed, discussed, and clarified. 
Screeners were using the tool as instructed and were given credit for the referral based on the 
updated guidelines and intervention tool (Table 6) documentation was updated on (Appendix D). 
Post-screening electronic follow-up messages to employees who had abnormal results 
improved from 2015 to 2016. In 2015, 11 electronic follow-up messages about abnormal 
screenings were documented in EHR—about 3% of the biometric screenings produced a 
electronic follow-up recommendation. In 2016, 108 electronic follow-ups, or 32% of the total 
number of screenings performed in that year, were documented in the EHR. Interestingly, 
documented phone follow-up messages decreased from 2015 to 2016. In 2015, there were 168 
documented phone follow-ups; this is about 50% of the total sample participant biometric 
screens performed in that year. In 2016, however, there were only 97 phone follow-ups—29% of 
the total number of screenings performed. In 2015, the total number of documented follow-up 
appointments that participants actually attended was 36 (11%). The total number of follow-up 
appointments that have been attended so far in 2016 is 58 (17%); by the end of the year, 2016 is 
projected to have a total of 116 follow-up appointments. The total number of documented 
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follow-up appointments for 2015 and 2016 is projected to be 152 (45%). The data suggests a 
decrease from 2015 to 2016 in the total number of documented referrals, although the percentage 
is similar at 13% (Table 3); it also indicates a clear increase in electronic follow-up messaging, a 
decrease in phone follow-up messaging, and an increase in the number of attended referrals. 
 
 
Figure 6. Total referrals for 2015 and 2016. Attended referrals and projection noted. 
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Quality Improvement Question 3 
The third QI question was, “Does a consistent referral management process, including 
tracking, and patient follow-up make a difference in observed participant volume at the health 
center?” 
 After reviewing 406 sample screens, 336 of 406 (83%), were usable for comparison 
between 2015 and 2016. Fifty of these screens (12%) belonged to participants who were no 
longer eligible for biometric screening in 2016. Twenty (5%) of the participant screens had 
missing data, e.g. did not complete the screen in 2016. In 2015, the total number of participants 
who attended their referral was 36 (11% of sample); in 2016, the total number of participants 
who attended their referral was 58 (17%) at the 6-month mark. By the end of 2016, it is projected 
that, 116 participants (35%) will attend referral appointments. The data indicated a positive trend 
in provider visits between 2015 and 2016: in 2015, 107 of 336 (32%) of 2015 participants 
returned to the health center for a visit. In the first 6 months of 2016, 96 of 336 (29%) screened 
participants returned to the health center for a provider visit. This projects to 192 (57% of 
screened employee) visits over 12 months, an increase of 85 provider visits over 2015. Again, 
the updated process an increase in follow-up visits over 2015. As part of sample analysis, 
population data collected by our team displayed a positive trend between 2015 and 2016. An 
increase of 203 visits, or 45% of the total number of employee visits, was recorded between 2015 
and 2016. A consistent referral management process, including tracking and patient follow-up, 
appears to have made a difference in observed patient volume at the health center. 
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 Figure 7. Office visits after biometric screen. 
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Quality Improvement Question 4 
The fourth QI question was, “What is the frequency of referrals for elevated BMI, 
elevated glucose, elevated cholesterol, and elevated lipids?” 
The total number of employees sampled for comparison across 2015 and 2016 was 406; 
the total number of usable screens in 2016 was 336. The total number of referrals for elevated 
glucose in 2015 was 93 (28%); in 2016, it was 104 (31%), an increase of 11 referrals. The 
frequency of referrals for elevated blood sugar was higher in 2016, a finding consistent with 
clinical observation in the health center. The total number of referrals for elevated blood pressure 
in 2015 was 60 (17%); in 2016, it was 50 (15%), a decrease of 10 referrals. The total number of 
referrals for elevated lipids in 2015 was 122 (36%); in 2016, it was 101 (30%), a decrease of 21 
referrals. The total number of referrals for elevated BMI in 2015 was 247 (74%); in 2016, it was 
194 (57%), a decrease of 53. The frequency of referrals for elevated blood pressure, elevated 
lipids, and elevated BMI all decreased from 2015 to 2016. These findings are interesting and 
deserve further study. Clinical observations in the health center do support fewer unnecessary 
referrals for these issues. The new guideline appears useful in providing a framework for 
screeners when making employee referrals. 
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Figure 8. Frequency of abnormal screens. 
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Chapter V: Discussion 
 The purpose of this QIP was to improve the referral process after biometric screening at a 
central North Carolina employee health center. Biometric screening referrals for 2015 and 2016 
were reviewed. This chapter discusses the study’s findings, implications, theoretical 
relationships, limitations, delimitations, and conclusions, and offers recommendations for 
practice derived from this study 
Importance of Referral Management After Biometric Screening 
Improving the post-biometric screening referral management process in this central NC 
employee health center made a difference: it improved clinical documentation, increased patient 
volume, improved clinical utilization of services, and directed referrals to local providers. In the 
project, there was an intervention into an ongoing process of performing annual biometric 
screens for employees and then referring employees with negative health markers (blood sugar, 
blood pressure, etc.) for follow-up testing and care with the clinic’s primary care provider or 
their own health care providers. A health center clinical team created a standardized referral 
process and tool as an intervention (Table 6). The team then collected employee health data via 
the usual annual biometric screenings and used the new standardized referral system to follow up 
with the participants. The team compared screening sample data (n = 336) from 2015, the year 
prior to the intervention, to data collected in 2016 from the same sample of participants; the 
comparison was intended to examine whether the standardized referral process increased the 
likelihood that patients would follow up on the negative health markers with the clinic’s primary 
care provider or with their own primary provider. Improvements were recorded. The employee 
health center improved its documentation of screening results by approximately 79%. The 
updated referral management process and tool improved participant follow-up by 23%. Patient 
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volume for the primary clinic provider increased from. Referrals to the clinic dietician increased 
by approximately 4%. Referrals to local primary care providers increased by approximately 11% 
(Figure 10). 
In addition, the health center identified, and improved documentation of, participants 
with abnormal blood sugar, blood pressure, lipids, and elevated body mass; review of the 
documentation revealed a decrease in referrals for elevated blood pressure, elevated lipids, and 
elevated body mass, while referrals increased for elevated blood glucose (Figure 8). 
Observations by the clinical biometric team also noted an improvement in the referral process.  
The reduction of referrals likely indicates fluctuations in biometric measurements as well as 
many questionable referrals. Looking back to 2014, the employee health center had very little 
data on the biometric values of participants or clinical utilization related to biometric screening, 
thus the importance of validating the intervention tool and biometric findings in future years is 
crucial for dissemination of project findings.  At this time, data and clinical observations support 
a high level of continued participant engagement in the biometric screening program (Table 3) 
and an increase in the number of employees utilizing the health center services between 2015 
and 2016.  
Furthermore, the updated referral process and creation of the referral tool generally 
increased employee acceptance of the biometric screening program. For example, the entire 
employee health team improved their electronic communication for clinical follow-up between 
2015 and 2016, while phone follow-up decreased. Telephonic follow-up messaging should be 
improved in future years, and this processes is being reviewed. Referrals to the primary clinic 
provider (NP) decreased; however it appears participants who completed the new screening 
process were more likely to return to the health center for clinical services.  Additionally, 
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referrals were more appropriately directed to the clinic dietician and to local primary care 
providers. These referral patterns should continue to be tracked for quality assurance. The quality 
improvement process in this health center should continue to be monitored to measure the 
sustainability of the process improvement and to validate the referral tool. Plainly, consistent 
referral guidelines using a standardized referral process and tool created a coherent clinical 
message and increased the number of employees using the employee health center between 2015 
and 2016.  
Implications 
This quality improvement process and tool development come out of a paradigm shift 
over the last decade toward allowing data-driven quality improvement to guide clinical practice 
A standardized quality improvement process can help employer wellness programs reduce risk 
factors that increase risk for nonclinical disease, including obesity, cardiovascular disease, 
diabetes, and hypertension. Dement (2015) clearly demonstrated an estimated return on 
investment (ROI) of $2.53 for every dollar spent on health promotion programs. An essential 
component of employer health promotion programs is efficient referral management after 
biometric screening; providers who aim for continued clinical success with biometric screening 
and patient follow-up in employee health should consistently review screening methods, results, 
patient counseling, and reported care for all screened employees (Dement, 2015). For example, 
many participants in our project resisted the idea of screening in the absence of disease or 
symptoms of disease; employees reported concerns about screening methods, screening results, 
effects of positive screens on cost of participant health care, and concern about employer bias. 
After two years spent evaluating changes to the process of referral management after biometric 
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screening and eliciting feedback from participants, the project was renewed due to program 
success. Data-driven quality improvement benefits clinical practice.  
Further evaluation should quantitatively and qualitatively measure employee interaction 
with both trusted health care providers and health screening. Valuable information can be 
gathered from surveying participants about consistent clinical staffing and clinic accessibility. In 
this study, point of care testing generated positive feedback from participants, and abnormal 
results were quickly identified and triaged. How does this process compare with traditional lab 
testing on measures of participant follow-up? QI is a continuous process and this project 
generated significant participant feedback. 
Improving referral management after biometric screening was a successful quality 
improvement project in this central NC company. This has demonstrated positive effects from 
changes in the documentation and referral process for employees who participate in a screening 
program. Early identification of nonclinical disease in a health insurance risk pool may impact an 
employee’s body measurements before irreversible clinical disease damage is done; it may also 
bend the cost curve associated with managing chronic disease. Further quantitative and 
qualitative research should be conducted to evaluate participant satisfaction with the process, 
identify additional possible clinical improvements, and estimate the cost savings of health 
promotion programs that include biometric screening. 
Relationship to Theoretical Framework 
  The theory of diffusion of innovation can help to conceptualize how employees in a 
corporation adopt innovations to their health care (Rogers, 2010). The theory of diffusion of 
innovation should ground future studies of the relationships between referral management, 
biometric screening, and health promotion in order to better understand how individuals and 
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groups accept or reject health care innovations (Figure 2). For example, many initiatives require 
leadership support to be successfully diffused; other initiatives, which diffuse laterally or from 
the bottom up, tend to be spread by employees’ peers and peer groups within their organization. 
Because this central NC employee health center has strong leadership and a hierarchical 
management structure, obtaining the support of company leadership for referral management 
after biometric screening was critical to program success. The referral management QI project 
was presented to the leadership in charge of corporate wellness before implementation; only 
once leadership was on board did the project move forward. Leadership support is imperative for 
diffusion of a new process (Greenhalgh, Robert, Macfarlane, Bate, & Kyriakidou, 2005). 
Individuals perceive change to their employer benefits differently; while the majority will follow 
leadership, some employees will continue to be skeptical of the process innovation. For example, 
our team increased the total number of referrals for 2015 to 2016 and also reported an increase in 
employee deferrals from 2015 to 2016 (Table 3). Further investigation using survey data would 
help clarify the reason for patient deferral, many of the participants do not use the health center, 
why? Observation and feedback by screeners indicate some participants are skeptical of the 
relationship between their employer and the health center. It this accurate, or just hearsay? The 
impact of the employer/employee relationship on diffusion of innovation, and specifically as it 
relates to referral management for nonclinical disease, should be the subject of further study 
(Rogers, 2010). 
Limitations 
There were four major limitations to this QIP. The first limitation was the scope of the 
project. Referral management after biometric screening was one part of a larger ongoing study 
on health promotion in this corporation. The employee health center coordinated with a larger 
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wellness team, and some data for the larger project was collected and reviewed before this QI 
project was begun (Table 1). The researchers overseeing the larger wellness study decided that 
this sub-project could be split off and managed independently by the local health center team. 
The primary investigator and project team have recommended further study and coordination 
with the entire wellness team before a final assessment of referral management in this population 
is made. 
The second major limitation is the potential conflict of interest between the health center 
team, the employer, and the program participants. The employee health center team has the 
advantage of being on site and convenient for participants, but its status as an employee benefit 
does create a potential conflict of interest and potential bias in the results in the QI study. Critics 
may argue that the health center team could benefit from an improvement in participant 
involvement, or that collecting health information about employees at work does not preserve 
objectivity or the privacy that should exist between health care provider, employer, and 
employee. Employers may use the data to identify unhealthy employees and terminate them from 
the company. The primary investigator acknowledges this type of behavior exists within 
unethical corporations and did not observe or perceive this behavior in this corporation. This 
limitation is acknowledged and limit the generalizability of any study or quality improvement 
project completed in an employee health center. However, participant privacy was rigorously 
protected. Screeners and providers collected data in a locked and privacy-protected environment. 
All electronic data was encrypted. Employers were given only aggregate data and have no access 
to employee health records without employee consent. Employees in this central North Carolina 
corporation were not forced to participate in the program; the program was a benefit of their 
employment and appropriate consents were discussed with all employees; further discussion of 
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informed consent was beyond the scope of this quality improvement project. The corporate 
wellness team managed informed consent and all details related to participant consent for the 
entire program. The primary investigator completed a formal IRB process and this QI project 
was deemed exempt, as it was a retrospective chart review that did not directly involve 
employees as human subjects.  
The third major limitation in this QI project is the role of the primary investigator (PI). 
The PI of this QIP also provided care for employees, and this could potentially have altered 
results to influence outcomes. However, it should be noted the PI did not receive any additional 
compensation or benefit from the QIP. This project would have been completed regardless of 
who was involved with the data collection. Resources for the project were limited; this limitation 
was also a benefit, as the primary provider of the health center was directly involved with 
improving care for employees. The intention of the QIP was to improve the quality of care being 
provided to employees and to identify employees who would benefit from increased provider 
involvement in their health care. Early identification of abnormal biometric screens and 
participation in the referral process was clearly beneficial to all involved in this project. The 
health center did have other providers, and they had very limited roles in this project as they 
were not full-time staff. The QIP required continuous involvement over the last two years. Most 
part time staff filled in coverage gaps and did not fully participate in follow-up process. They 
screened participants, used the intervention tool, entered data, made referrals, and did not have 
any further contact with participants. Thus most of these referrals had no contact with the PI and 
did not receive documented follow-up from the PI. Despite this limitation, documented follow-
up with participants increased. Lastly, referrals to the PI decreased during this project, and 
deferrals increased—a finding that may mitigate concern about potentially biased results. 
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The last major limitation relates to health center staff referring patients to other health 
center staff. As previously stated, no financial incentives were received by clinical staff involved 
in the QIP. In fact, staff members volunteered hundreds of additional hours to this employee 
QIP. The referral improvement process, which is intended to match abnormal screens to the most 
appropriate available provider, underwent a transparent team QIP. It should be noted that internal 
referrals trended downward from 2015 to 2016 (Figure 10), and the health center screened fewer 
employees between 2015 and 2016 (Table 3). All limitations acknowledged in this QIP highlight 
the importance of continued study and reflection for employee health center providers and 
administrators. 
Delimitations 
 Delimitations include exclusion of normal biometric screens from examination; a limited 
number of screeners; exclusion of demographic data; and lack of advanced statistical analysis. 
The sample examined in this employee health population comprised abnormal screens only, and 
as the total number of employees screened by the health center decreased between 2015 and 
2016, the sample size of abnormal results also decreased. Comparing data for one to two more 
years would provide a better approximation of referral patterns over time. Additionally, 
employees with normal screens should be encouraged to continue to take part in screenings each 
year. Not only would this increase the pool of potentially abnormal scans available for tracking 
by the QIP team, but having a consistent number of employees regularly undergoing screenings 
would ensure an appropriate number of screenings for meaningful examination. 
The limited number of screeners was intentional. This project required that all screeners 
behave in a consistent manner during data collection and referrals; limiting the number of data 
collectors was crucial to the project’s success, and it also helped to keep costs down. Participants 
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with normal health screens were not included in the sample since they did not need referrals; 
however, further study comparing the sample to a control group would provide further data on 
clinical utilization, and the health center team has discussed a further study of this type. 
Collection and evaluation of demographic data and advanced statistical analysis are being 
performed by the research team on the larger project; these were beyond the scope of this QIP. 
Conclusions and Recommendations for Practice 
Using a standardized referral process and intervention tool improved the biometric 
screening program in this central NC employee health center. Basic process changes in referral 
management—the use of a standardized referral tool—made a difference in referral patterns after 
biometric screening. Our employee health center recommends using a standardized referral 
process and creating tools that fit the particular needs of a participant population. Collecting data 
before any intervention is recommended. Screening data is helpful to providers when it’s easily 
available, and a copy of each employee’s screening data should be included in each employee’s 
health record. After an abnormal screen, participants should be given a referral using a 
standardized work sheet. Using uncomplicated and consistent principles, our health center 
improved referral management after biometric screening. 
Employee health centers offer a unique and challenging environment for studying referral 
management after biometric screening. Health center teams should focus on contacting and 
following up with interested patients who have been given referrals, while continuing to work 
with patients who deferred services. Employee health centers will continue adding and losing 
participants and should continue following participants and encouraging participation in the 
biometric wellness program. Expanding and coordinating employee health services to meet the 
growing need of employees with obesity and diabetes is recommended. Adding hemoglobin A1C 
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testing for participants with an elevated fasting glucose is a logical addition to biometric 
screening. Additional resources focusing on health promotion and disease management programs 
with participants utilizing employee health will benefit from managing and following referrals 
after biometric screening. 
Referral variables related to gender, race, and socioeconomic status should also be 
explored to further test the validity of this QIP. Health care access and affordability for 
employees who have abnormal screens are significant issues which are addressed in the 
literature, and not specifically analyzed in this QIP. Lastly, employees and employers must both 
acknowledge their role in identification, treatment, and management of heart disease, diabetes, 
and obesity. The cost of care for this employee population will be significant as it ages. Using 
the employee health care models to identify and manage chronic disease developed by the North 
Carolina Institute of Public Health (NCHIP), The Centers for Disease Control (CDC) and US 
Census Data (2016) are the next logical steps in planning further research on this pivotal 
population in North Carolina. 
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Table 4 
Sample of Search and MESH Terms Used for Project 
  
1. ((“manpower”[Subheading] OR “manpower”[All Fields] 
OR “employees”[All Fields]) AND (“referral and 
consultation”[MeSH Terms] OR (“referral”[All Fields] 
AND “consultation”[All Fields]) OR “referral and 
consultation”[All Fields] OR “referrals”[All Fields])) AND 
(“loattrfull text”[sb] AND “2011/11/02”[PDAT] : 
“2016/10/30”[PDAT] AND “humans”[MeSH Terms] AND 
English[lang] AND (jsubsetaim[text] OR jsubsetn[text] OR 
medline[sb]) AND “adult”[MeSH Terms]) AND 
((jsubsetaim[text] OR medline[sb]) 
79 papers 
2. biometric[All Fields] AND (“diagnosis”[Subheading] OR 
“diagnosis”[All Fields] OR “screening”[All Fields] OR 
“mass screening”[MeSH Terms] OR (“mass”[All Fields] 
AND “screening”[All Fields]) OR “mass screening”[All 
Fields] OR “screening”[All Fields] OR “early detection of 
cancer”[MeSH Terms] OR (“early”[All Fields] AND 
“detection”[All Fields] AND “cancer”[All Fields]) OR 
“early detection of cancer”[All Fields]) AND 
(“occupational health”[MeSH Terms] OR 
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(“occupational”[All Fields] AND “health”[All Fields]) OR 
“occupational health”[All Fields] OR (“employee”[All 
Fields] AND “health”[All Fields]) OR “employee 
health”[All Fields]) 
27 papers 
3. (employee[All Fields] AND (“referral and 
consultation”[MeSH Terms] OR (“referral”[All Fields] 
AND “consultation”[All Fields]) OR “referral and 
consultation”[All Fields] OR “referral”[All Fields]) AND 
(“diagnosis”[Subheading] OR “diagnosis”[All Fields] OR 
“screening”[All Fields] OR “mass screening”[MeSH 
Terms] OR (“mass”[All Fields] AND “screening”[All 
Fields]) OR “mass screening”[All Fields] OR 
“screening”[All Fields] OR “early detection of 
cancer”[MeSH Terms] OR (“early”[All Fields] AND 
“detection”[All Fields] AND “cancer”[All Fields]) OR 
“early detection of cancer”[All Fields])) AND 
(“2011/11/02”[PDat] : “2016/10/30”[PDat] AND 
“humans”[MeSH Terms] AND “adult”[MeSH Terms]) 
6 Papers 
4. ((“occupational health”[MeSH Terms] OR 
(“occupational”[All Fields] AND “health”[All Fields]) OR 
“occupational health”[All Fields] OR (“employee”[All 
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Fields] AND “health”[All Fields]) OR “employee 
health”[All Fields]) AND (“economics”[MeSH Terms] OR 
“economics”[All Fields] OR “economic”[All Fields]) AND 
impact[All Fields]) OR (“wellness programmes”[All Fields] 
OR “health promotion”[MeSH Terms] OR (“health”[All 
Fields] AND “promotion”[All Fields]) OR “health 
promotion”[All Fields] OR (“wellness”[All Fields] AND 
“programs”[All Fields]) OR “wellness programs”[All 
Fields]) AND (systematic[sb] AND “loattrfull text”[sb] 
AND “2011/11/02”[PDat] : “2016/10/30”[PDat] AND 
“humans”[MeSH Terms] AND English[lang] AND 
jsubsetaim[text] AND “adult”[MeSH Terms]) 
43 papers 
5. http://scholar.google.com.jproxy.lib.ecu.edu/scholar?q=The
+rising+cost+diabetes+and+obesity+and+hypertension+and
+lipids+and+employees+of+BCBS+NC&btnG=&hl=en&as
_sdt=1%2C34&as_ylo=2012 
52 papers 
 
 
 
Note. Sample of search methods in PubMed and Google scholar, additional searches in 
CINAHL, Google, and Bing search engines. 
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Table 5 
Biometric Health Testing, 2015 guidelines 
        
  
Normal  
 
B High 
 
High 
 
Low 
 
 Refer & F/U  
 
 
Total Chol <200 >200 >250 **  Over 250  
Trig <150 150–199 >200 **  Over 200  
HDL 50–60 ** ** <40 < 40 with 
another elevated 
category. 
 
LDL <100 130–159 >160 <100 >160  
Glucose 
 
60–100 100–125 126 <60 >101  
BP Systolic 
BP Diastolic 
Body Mass 
Index (BMI) 
<120 & >90 
< 80 & >60 
18–25 
 
 
120–139 
80–90 
25–28 
>140 
>90 
>28 
TBD 
TBD 
<18 
>140 
>90 
>28 
 
 
 
Note. Chol = Cholesterol. Trig = Triglycerides. HDL = High-Density Lipoprotein. LDL = Low-
Density Lipoprotein. BP = Blood Pressure. B = Borderline. Referral time frame not 
F/U = Follow-up. TBD = To Be Determined. 
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Table 6 
Updated biometric health testing: standard referral, same-day referral, and immediate consult 
values, 2016 
 Positive screen Standard referral Same Day Referral Immediate Consult 
or offer to call PCP 
Priority  
High Glucose >100 Fasting 
>140 Non-Fasting 
100—199 Fasting 
140–199 Non-Fasting 
NP 3–5 days 
200—249 Fasting 
200–399 Non-Fasting 
NP 
 
>250 Fasting  
>400 Non-Fasting 
NP 
1 
Low Glucose <60 
Provide snack 
 
 
50–60 
NP 
 
<50 
NP 
 
 
BP Systolic >120 140–159  
NP 1 week 
160–179 
NP 
>180 or <90 
NP 
2 
BP Diastolic 
 
>80 
 
90–99 
NP 1 week 
100–109 
NP 
>110 or <50 
NP 
Total Chol >200 240–349 
RD 2 weeks 
>350 
NP 
 
3 
Trig >150 150–199 
RD 2 weeks 
>200 
RD 
 
HDL <40 <40 
RD 2 weeks 
  
LDL >130 >160 
RD 2 weeks 
  
 
 
Body Mass 
Index (BMI) 
 
>28 
 
30.0—39.9 
RD 2 weeks 
>40 
<18 
RD 
 
4 
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Note: 
 Bolded values = Immediate consult with provider. 
 If more than one value requires a standard referral, the Priority order determines what the referral is made for. 
 If 3 or more values are positive but not high enough for referral on their own, provide referral to NP for 2 weeks. 
 If any values are positive or if they have questions, offer option of consult with EAP, RD, or NP. 
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Table 7 
Watson’s Ten Carative Factors 
  
1. Humanistic system of values 
2. Faith-Hope 
3. Sensitivity to self and others 
4. Developing helping-trusting, caring relationships 
5. Expressing positive and negative feelings and emotions 
6. 
7. 
8. 
9. 
10. 
Creative, individualized, problem solving caring process 
Transpersonal teaching-learning 
Supportive, protective, and corrective environment 
Human needs assistance 
Existential-phenomenological and spiritual forces 
 
Notes. (Watson 1999, 2008). Reviewed in McEwen &Willis (2011). Humanistic = human values 
based on respect, openness, and understanding. Transpersonal = An intersubjective human to 
human relationship, both the nurse and the patient are affected by experience. Existential and 
spiritual forces = acceptance of a larger life process, a binding life-force inherent in all humans. 
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Table 8 
Reviewed sample referrals by abnormal screen, percentage, and follow-up 
 
 
Elv Glu 
2015 
Elv Glu 
2016 
Elv BP 
2015 
Elv BP 
2016 
Elv Lip 
2015 
Elv Lip 
2016 
Elv BMI 
2015 
Elv BMI 
2016 
Freq of R 93 104 60 50 122 101 247 194 
Tot 
2015–
2016 
* 197 * 110 * 223 * 441 
yes/ total 22.91% 25.62% 14.78% 12.32% 30.05% 24.88% 60.84% 47.78% 
no / total 62.07% 52.96% 70.20% 66.26% 54.93% 53.69% 24.14% 30.54% 
 
Notes: Elv = Elevated. GLU = Glucose. BP = Blood Pressure. Lip = Lipids. BMI = Body Mass 
index. Tot = Total. 
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Figure 9. Referral by abnormal screen and percentage.  
Yes = referral. No = No referral. Elv = elevated. Glu = glucose. BP = blood pressure. Lip = Lipids. 
BMI = body mass index 
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Figure 10. Referral type. 
  
0 50 100 150
Referred to NP 2015
Referred to NP, RD 2015
Referred to NP,RD 2016
Referred to NP 2016
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Referred to RD 2016
Referred to PCP 2015
Referred to PCP 2016
Referred to OB/GYN 2016
Referred to Carolina Adv 2015
Referred to Carolina Adv 2016
Referred to Bariatrics 2015
Referred to Bariatrics 2016
Defers any referral 2015
Defers any referral 2016
Biometric referral type
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Appendix A 
ECU IRB Approval Form 
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Appendix B 
Biometric clinical flow and documentation 
 
Biometric flow of patients at BCBS NC-Durham Reception area = Medical assistant (MA) or 
available clinical staff will manage reception desk and start data collection tool using Premise 
Health software and electronic medical record. Screening Rooms 1, 2, & 4 = MA, registered 
nurse, or registered dietician. Screening by cholestech. Screens include fasting lipids, glucose, 
height, weight, and blood pressure. Room 3 = Exam room, NP or alternate staff for clinical 
exam. Overflow = Extra waiting area, front desk will manage overflow. A couch and snacks will 
be available for patients requiring extra care, refreshment, or a short rest (see Figure 3). 
 
Reception  
Area
Check -
In
Rm 1
Screener 
and data 
collector  
Rm 2 
Screenr 
and data 
collector  
Rm 3
Exam 
Room
Rm 4 
Screener 
and data 
collector  
Overflow
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Chart Review Flowsheet 
 
1. Does the chart have a copy of a biometric screen and consent? 
+ / - 
If (+) move on to step 2. If (-), look for screen and consent. Note on spreadsheet and move on to 
next chart. 
 
 
 
2. Was the screen positive (+) (abnormal) or negative (-) (normal). 
+ / - 
If abnormal move on to step 3, if normal, did the patient return to health center? Stop, document 
and move on to next chart. 
 
 
 
3. Was a referral indicated and completed (+/-)? Was the referral internal or external? 
If referral was indicated and completed (+), indicate internal or external and move to step 4. 
 + / - 
If (-), stop, document, and move on to next chart. 
 
 
 
+  
 
 
 
 
+
/
_  
 
 
 
 
+  
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4. Did the health center follow-up on the referral (documentation in EHR)? 
 + / - 
If (+) document and move on to step 5, if (-) document and move on to step 5. 
  
 
 
5. Did the patient return to the health center or follow-up on the message from the health center? 
 Document + /—and stop. 
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Documentation Workbook Example 
Data will be kept in a password protected Microsoft Excel Workbook, see screen shot. 
 
Chart Number, Referral for glucose, Standard Referral for BP, Standard Referral for Lipids, 
Standard Referral for BMI, No Referral Required, Same Day Referral / Comments, Appointment 
Made, Pt Declines Apt, Outside Referral, Referred To, Appointment Attended Portal Email 
Follow-up, Phone Follow-up 
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Appendix C 
Timeline for Biometric Project 
 
 Dates Activity  
1. 8/15–9/15 Completed follow-up on 2015 screens, started literature review 
2. 
3. 
4. 
5. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
8/29/2015 
9/1–12/1/16 
9/8–9/11/15 
9/13–9/16 
9/16–12/1/16 
9/19/2015 
10/8/2015 
10/12–10/30 
10/30/2015 
11/01/15 
11/2/15 
11/3–11/30 
11/15/15 
11/30/2015 
12/6/2015 
12/6/-12/21 
12/21–1/4/16 
Jan 2016 
Jan 2016 
1/26/2016 
Feb 2016 
March 2016 
Completed CITI IRB training 
Explore Pubmed, CINAHL, NIH, CDC databases  
Submission of project idea and draft of abstract 
Completed DNP intensive training 
Theory review on diffusion of innovation 
Submitted table and abstract to faculty members 
Reviewed, sorted, and presented data on 2015 biometric screen 
Reviewed data findings with Director of Site Operations and Med Director 
Add Diabetes education project, not part of ECU project 
Re-submit abstract, obtain final approval. 
Submit Draft of project for feedback. 
Work on final project 
Premise work group and BCBS meeting 
Submit final draft of project 
Submit project Log. 
Project planning and work assignments 
Break-Gene Lit review time. 
Prepare for IRB submission. 
Set up project health database, workbook, and EMR. 
Start Biometric screens and collecting data. Work on theory review. 
Attend DNP intensive training. 
Review project. 
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25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
April 2016 
May 2016 
June 2016 
July 2016 
Aug 2016 
Sept 2016 
Sept-Nov 16 
Dec 2016 
Data collection and review. 
Data collection. 
Attend DNP intensive training, data collection. 
Sort and Scrub Data. 
Review and Analyze Data. 
Present data and project at Intensives. 
Finish Project, plan for 2017. 
Graduate. 
 
Notes. Timeline is projected. 
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Appendix D 
Biometric Project Screening Tool 
CONFIDENTIAL BIOMETRIC HEALTH TESTING 
 
Name: __________________________________ Date: __________ Date of Birth: __________ 
Male □  Female □   Height: _________   Weight: _________ 
Fasting: Yes□ No□   Cotinine: Positive □ Negative □ Pregnant: Yes □ No □ 
SCREENING RESULT GUIDELINES 
 
RECOMMENDATIONS 
FOR AT RISK LEVELS 
(NON-PHARMACEUTICAL) 
 
Body Mass 
Index (BMI) 
 
 
 
 
 
18.5—24.9 
25.0—29.9 
≥ 30 
 
Healthy Weight 
Overweight 
Obese 
 
 BMI may not account for variations in 
muscle mass and body fat 
 Reduce weight by 5–10% 
 Choose more nutrient rich foods 
Blood 
Pressure 
 
 
 
 
Systolic 
< 120 
120–139 
≥ 140 
Diastolic 
< 80 
80–89 
≥ 90 
 
 Ideal 
 Prehypertension 
 Hypertension 
LDL 
(“Bad” 
Cholesterol) 
 
 
 
 
 
 
< 100 
100–129 
130–159 
160–189 
≥190 
Ideal 
Near / Above optimal 
Borderline High 
High 
Very High 
 Reduce your weight 
 Reduce cholesterol, saturated fat, and 
trans fat intake 
 Increase soluble fiber intake 
 Increase physical activity 
HDL 
(“Good” 
Cholesterol) 
 
 
 
 
Men 
< 40 
> 60 
Women 
< 50 
> 60 
 
 High Risk 
 Desirable 
 
Total 
Cholesterol 
 
 
 
 
 
 
 
< 200 
200–239 
≥ 240 
 
Desirable 
Borderline High 
High Risk 
 
 Reduce your weight 
 Reduce cholesterol, saturated fat, and 
trans fat intake 
 Increase physical activity 
 
Triglycerides 
 
 
 
 
 
 
 
 
< 150 
150–199 
200–499 
≥ 500 
 
Normal 
Borderline High 
High 
Very High 
 Reduce your weight 
 Limit alcohol if you drink 
 Limit sugary drinks 
 Increase physical activity 
 Eat fish high in omega-3 fatty acids 
(salmon, mackerel, and tuna) 
Glucose / 
Blood Sugar 
 
 
 
 
Fasting 
< 100 Normal 
100–125 Pre-Diabetes 
> 126 Diabetes 
 
Non-Fasting 
<140 Normal 
40–200 Pre-Diabetes 
> 200 Diabetes 
 
 Reduce your weight by 5–10% 
 Reduce cholesterol, saturated fat, and 
trans fat intake 
 Increase physical activity 
 
Recommendations: It is recommended that you provide a copy to your primary care provider and if there are 
abnormal findings, schedule an appointment for further testing. These results are considered preliminary and are 
not a diagnosis. 
 
 
 
Signature of Health staff or Agent: ____________________________________________________ 
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Cholestech LDX 
 
 
“The Alere Cholestech LDX System is a small, portable analyzer and test cassette system. It uses 
reflectance photometry to measure the amount of substances in the blood.” In this project it will 
measure blood glucose and blood lipids (Alere Cholestech LDX System User Manuel, 2015). 
 
 
 
 
